Abstract Purpose: To develop an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the simultaneous determination of 7 major components of Ginkgo leaf (kaempferol, quercetin, isorhamnetin, ginkgolides A, ginkgolides B, ginkgolides C and bilobalide) 1.232, 0.240, 0.200, 1.330, 0.960, 0.696, 0.470 
INTRODUCTION
The extract of Ginkgo biloba (Ginkgo, Ginkgoaceae) leaves has been considered as valuable medicine and dietary supplements for more than 40 years. Pharmacology experiments showed that it is helpful to the prevention and treatment of cardiovascular diseases [1, 2] and cerebral insufficiency [3] [4] [5] [6] [7] . Such pharmacological activities are attributed to the flavonoid glycosides and terpene lactones.
According to the Food and Drug Administration of the United States, botanical drug products should be investigated with regard to blood levels of known representative markers, active constituents, and major chemical constituents.
In this study, a simple, rapid and sensitive ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed for the simultaneous determination of the 7 major components Ginkgo Biloba leaves (kaempferol, quercetin, isorhamnetin, ginkgolides A, ginkgolides B, ginkgolides C and bilobalide) in dog plasma.
EXPERIMENTAL Chemicals
The reference standards of kaempferol (KMF), quercetin (QCT), isorhamnetin (ISR), ginkgolides A (GA), ginkgolides B (GB), ginkgolides C (GC) and bilobalide (BB) and domperidone (DPD) (IS) were purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). The purity of QCT and GC was 96.5 and 97.1 %, respectively. The purity of the remaining reference standards was more than 99 %. LC/MS grades of methanol and acetonitrile were obtained from Fisher Scientific (Fair Lawn, NJ, USA), HPLC grade of formic acid was supplied by ROE Scientific (Newcastle, USA), and ultrapure water was generated from the Synergy UV water purification system (Millipore Corp, USA).
Instrumentation and chromatographic conditions
The UPLC-MS/MS system used was composed of an Acquity UPLC system (Waters Corp., Milford, MA, USA) and a TQS triple quadrupole tandem mass spectrometer (Waters Corp., Milford, MA, USA) equipped with an electrospray ionization (ESI) source. Data were acquired and processed using MassLynx 4.1 software (Waters Corp., Milford, MA, USA).
Chromatographic separation was performed on an ACQUITY UPLC BEH C18 column (100 mm × 2.1 mm ID, 1.7 µm; Waters Corp., Milford, MA, USA). The column temperature was maintained at 40 °C and the auto-sampler was conditioned at 4 °C. The mobile phase was composed of 0.1 % formic acid aqueous solution (A) and acetonitrile (B) at a flow rate of 0.4 mL/min in only 4.0 minutes. Gradient condition of the mobile phase was as follows: 5 % B at 0-1.0 min; 5 → 40 % B at 1.0-1.5 min; 40 % → 43 % B at 1.5-3.0 min, then the system was equilibrated using the initial condition (acetonitrile-water, 5:95, v/v) for 1.0 min. The injection volume was 3 µL and the partial loop with a needle overfill mode was used for sample injection.
Mass spectrometer was operated in the negative ion mode using a multiple reaction monitoring (MRM) approach. Cone voltage was set at 30 V, and source and desolvation temperatures were set at 150 and 400 °C, respectively. Nitrogen was used as the desolvation gas and cone gas with the flow rates of 800 and 150 L/h, respectively. Argon was used as the collision gas at a pressure of approximately 3.4×10 -3 mbar. The specific parameters for each analyte are shown in Table 1 .
Preparation of standards and quality control
Seven separate primary stock solutions for KMF, QCT, ISR, BB, GA, GB, and GC were prepared by dissolving the accurately weighed reference compounds in methanol at the concentrations of 110, 125, 123, 104, 100, 145, 147 μg/mL, respectively. The stock solutions were then mixed together and serially diluted with methanol to produce a series of standard or quality control (QC) working solutions at the desired concentrations. DPD (IS) was also prepared as a stock solution of 192 μg/mL in methanol and diluted with methanol to yield a working solution of 576 ng/mL. All these solutions were stored at 4 °C and brought to room temperature before the solutions were used. .0, and 294.0 ng/mL for GC. Low-, medium-, and high-level QC samples were also prepared in the same way to obtain concentrations of 3.08, 30.8, and 616 ng/mL, respectively, for KMF; 0.6, 6.0, and 120 ng/mL, respectively, for QCT; 0.492, 4.92, and 98.4 ng/mL, respectively, for ISR; 3.328, 33.28, and 665.6 ng/mL, respectively, for BB; 2.4, 24.0, and 480 ng/mL, respectively, for GA; 1.74, 17.4, and 348 ng/mL, respectively, for GB; and 1.176, 11.76, and 235.2 ng/mL, respectively, for GC.
Animals and sample handling
Male adult beagle dogs (SPF animal, 11.1 ± 0.3 kg, certificate number SCXK（Jing）2013-0007) were obtained from the Beijing Tongli experimental animal farms. Animals were housed in a temperature-controlled house. Water and standard laboratory food were available ad libitum. The experimental protocols were conducted in accordance with The Guiding Principles for the Care and Use of Laboratory Animal (published by Ministry of Science and Technology of the People's Republic of China, Chapters 2, 3 and 5) and were approved by the Institutional Animal Care and Use Committee of the Beijing University of Chinese Medicine.
Blood samples were collected before and after the drug administration. The steps of the sample treatments are described as follows: 500 µL plasma was placed in an Eppendorf tube; then 20 µL of IS solution and 500 µL of 25 % hydrochloric acid were added to the tube and the mixture was vortex mixed for 1 min. Then the plasma sample was hydrolyzed for 30 min in a water bath at 80 °C, and the hydrolyzed and cooled sample was vortex mixed for 3 min after adding 2.0 mL acetidin. The mixture was centrifuged at 8000 rpm for 10 min to separate the water phase from the organic phase (I). The water phase was repeatedly spiked with 2 mL acetidin by vortex mixing for 3 min and centrifuged at 8000 rpm for 10 min to separate the water phase from the organic phase (II). The organic phase (I) and the organic phase (II) were put together and transferred to a clean centrifuge tube. The mixture was evaporated to dryness under a gentle stream of nitrogen. The residue was reconstituted with 200 μL methanol; then the solution was centrifuged at 12000 rpm for 15 min, and finally, an aliquot of 3 μL of the solution was injected into the chromatographic system for measurements.
Method validation

Selectivity
Selectivity was evaluated by comparing the chromatograms of six individual blank dog plasma samples with those of corresponding standard plasma samples spiked with the analytes and IS, and plasma samples obtained after oral administration of drugs.
Calibration curves and LLOQ
To evaluate linearity, the calibration curves were confirmed by plotting the peak area ratios of each analyte to IS versus the concentration of calibration samples through the linear least squares regression calculation with the suitable weighting factor of 1/x. A correlation coefficient (r) should be greater than 0.99 for assessment of linearity. The concentrations of QC samples or the test samples were calculated using the regression equations gained from the calibration curves. The LLOQ for the analytes were the lowest concentration point of the calibration curve. Analytes response at the level of LLOQ should be at least five times that of the blank plasma.
Recovery and matrix effect
The extraction recoveries and matrix effects of analytes were determined by analyzing six replicates of QC samples at three concentration levels. The extraction recoveries were calculated by comparing the response obtained from QC samples spiked before extraction with those from QC samples spiked in post-extracted blank dog plasma at the same concentrations. The matrix effects were evaluated by comparing the response obtained from QC samples spiked post-extraction blank dog plasma with those from QC samples spiked in before extracted pure water at the same concentrations. The matrix effects should be neglected if the ratio is in the range of 85 -115 %.
Intra-and inter-day precision
Precision were evaluated by analysis of QC samples at low, medium and high concentrations with six replicates on the same day and three consecutive days. Precision was expressed as the intra-and inter-day RSD. The precisions were required to be less than 15 %, except for the low QC samples where the precision should be below 20 %.
Stability studies
Stability studies were conducted at three QC levels with three replicates in different conditions that occurred during sample analysis. The shortterm stability was evaluated with QC samples stored at room temperature for 6 h. The longterm stability was assessed by QC samples kept at -80 °C for 1 month. The post-preparative stability was measured by determining QC samples maintained in the auto-sampler conditions at 4 °C for 12 h. The samples were considered to be stable if the deviation from the nominal concentration was within the acceptable limits of ±15 %. Table 2 lists the regression equation, correlation coefficients, linearity ranges, and LLOQ of the analytes. All calibration curves exhibited good linearity with the correlation coefficients (r) higher than 0.9952. The LLOQ were 1.232, 0.240, 0.200, 1.330 0.960, 0.696, and 0.470 ng/mL for KMF, QCT, ISR, BB, GA, GB, and GC, respectively.
RESULTS
Specificity and selectivity
Linearity and LLOQ
The calibration curves were confirmed by plotting the peak area ratios of each analyte to IS versus the concentration of calibration samples through the linear least squares regression calculation with the suitable weighting factor of 1/x.
Recovery and matrix effect
The extraction recoveries and matrix effects of all analytes at different levels of concentrations are shown in Table 3 . The recoveries of three-level QC samples ranged from 77.68 % to 105.07 %. The matrix effects derived from QC samples were in the range of 85.09 % -113.14 %. The results showed that the plasma matrix effect was negligible under the current conditions.
Intra-and inter-day precision
The intra-and inter-day precisions are shown in Table 4 . The precisions of KMF, QCT, ISR, BB, GA, GB, and GC calculated as the RSD at three concentrations were lower than 10 % for intraand inter-day assays for quality control. The results demonstrated that the precision of this method was acceptable.
Stability
The stability experiments aimed at testing samples under all possible conditions the samples might experience after collection and prior to analysis. The summaries are listed in Table 5 . The stability of the analytes calculated as the RSD at three concentrations was lower than 15 % for quality control. The results demonstrated that the precision of the study was acceptable.
DISCUSSION
The method to determine the flavonol aglycones QCT, KMF, and ISR in G. biloba products was completed by a single laboratory validation [8] , and the method was evaluated in the collaborative laboratory in 2007 [9] . A rapid quantitative analysis of GA, GB, GC, and GJ, and BB in ginkgo dietary supplements was established [10] . Up to now it is known that an LC-MS/MS was developed for simultaneous measurement of eight ginkgo flavonoids (QCT, KMF, and ISR) and terpenoids (BB, GA, GB, GC, and GJ) in vitro [11] . In a more recent study, on the basis of LC-MS/MS working in the MRM mode, an analytical method was established to simultaneously determine 24 main bioactive components, including flavonol glycosides, terpene lactones, biflavones, proanthocyanidins, and ginkgolic acids in G. biloba leaves [12] . FDA suggested that botanical drug products should be investigated with regard to blood levels of known representative markers, active constituents, and major chemical constituents. The pharmacokinetic studies of G. biloba and its preparations were mostly implemented in rats, which most only for flavonols or lactones of single preparation [13] [14] [15] [16] [17] . In this paper, a UPLC-ESI-MS/MS method for simultaneous determination of three flavonoids (KMF, QCT, and ISR) and four lactones (GA, GB, GC, and BB) in beagle dog plasma was described for the first time. In addition, the current method also offers other advantages over existing methods, such as shorter analysis time (4.0 min). This method can be applied to a pharmacokinetic study of different G. biloba L. extract preparations after oral administration to beagle dog. 
CONCLUSION
The developed methods meet the requirements for biological sample analysis.
They can be applied to the pharmacokinetic studies of kaempferol, quercetin, isorhamnetin, ginkgolides A, ginkgolides B, ginkgolides C and bilobalide in dog plasma when Ginkgo leaf preparations are administered. 
